Amyotrophic lateral sclerosis NMJ Hypokalaemic periodic paralysis Clinical trials Butyrylcholinesterase Rare diseases Knockout mouse Cercopithecus aethiops Ca V Mutation LRP4 MuSK Motoneuron Myotonia congenita Non-dystrophic myotonia Developmental Cholinergic Treatment delay Epidemiology Animals Actin cytoskeleton Precision medicine Deficiency Biological Markers Aging Agrin Cytokines IL-22 binding protein isoform Genetic Association Studies Expression Actionable genes Amyloid Autoimmune Congenital myopathy HSP70 Heat-Shock Proteins/genetics/metabolism Frontotemporal Dementia/genetics Congenital myasthenic syndrome Alzheimer's disease Nondystrophic myotonias Drainage M3243AG HypoPP ¼ hypokalaemic periodic paralysis Amyotrophic Lateral Sclerosis/genetics Acetylcholinesterase Acetylcholine receptor clustering Cell-cell communication COS Cells Wnt Gating pore current Abbreviations CMAP ¼ compound muscle action potential Myotonic Dystrophy Body Patterning Humans Cognitive decline Neuromuscular junction Brain Female COVID-19 HEK293 Cells Aged Cluster Analysis Awareness Receptors CLS Mexiletine Jonction neuro musculaire ALS HDAC motor neuron neuromuscular junction reinnervation Cell Cycle Proteins/chemistry/genetics/metabolism Multiple sclerosis Synaptotagmin2 Hereditary/genetics Conduction disease Chloride channel Adult SMA Paramyotonia congenita Congenital myasthenic syndromes Database GFPT1 Calcium channel Lithium chloride IL22RA2 Jonction neuromusculaire Minigene Diseases Longitudinal progression Acetyltransferase Embryo Frontotemporal lobar degeneration MBNL Neuromuscular disease Chemokines Experimental disease models Jonction Neuromusculaire NMJ Gene Expression Regulation Dimerization 80 and over Disability CMS Heart failure Distal myopathy Clinical trial